More On

Leukemia & Lymphona Society: A model non-profit

Organization's research funding saved Bruce Collins' life

I’ve never written about the most important non-profit organization in my life—until now. Indeed, if it were not for the Leukemia & Lymphoma Society (LLS) I would not have a life at all. That is not an exaggeration.

I mention LLS now because this is the 10th anniversary of my leukemia diagnosis. On my birthday in 2002, I found out I had a rare and incurable blood cancer called chronic myelogenous leukemia (CML). The treatment options at the time were not good, and I was likely to live, at most, only another eight years. However, just a few months before I got the bad news, the Food & Drug Administration had approved a new drug called Gleevec, the first of the so-called molecularly targeted therapies. That means the drug kills only the cancer cells without harming healthy cells. I started taking Gleevec and was almost back to normal within weeks. I still take that big orange pill every day. The result? My oncologist says I’m more likely to die with CML than of it.


Bruce D. Collins

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.